Divis Labs Q3 Results: Profit rises 17% YoY to Rs 358 crore

Pharma major Divis Laboratories on Saturday reported a consolidated net profit of Rs 358 crore for the quarter ended December 2023, up 17% from Rs 306 crore posted in the same period last year.

Revenue from operations in the reporting period increased 9% year-on-year to Rs 1,855 crore, compared with Rs 1708 crore in the corresponding period of last year.

EBITDA for the third quarter jumped 20% year-on-year to Rs 489 crore, as against Rs 409 crore in the same quarter of last year. Meanwhile, margins improved to 26.4%.

Profit before Tax (PBT) for the quarter came in at Rs 489 crore, as against a PBT of Rs 435 crore during the corresponding quarter of last year.

Material consumption for this quarter came to be about 39% of sales revenue.

For the nine-month period ended December 2023, the company earned a PAT of 1,062 crore, down 29% year-on-year from Rs 1,502 crore in the same period of last year.The company reported a total income of Rs 5804 crore in the 9MFY24 period. Forex gain for the current 9-month accounted for Rs 32 crore as against Rs 134 crore during the previous 9-month period.

More to come….

(You can now subscribe to our ETMarkets WhatsApp channel)

(What’s moving Sensex and Nifty Track latest market news, stock tips and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price